Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TSLA
3. TXN
4. NOW
5. GOOG
6. CSX
7. AMD
8. IBM
9. KNX
10. LVS

Go back to Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets
LIGAND PHARMA (NASDAQ: LGND) Delayed: 303.79 -0.47 (0.15%)
Previous Close $304.26    52 Week High $139.79 
Open $300.47    52 Week Low $82.07 
Day High $307.48    P/E 706.49 
Day Low $300.00    EPS $0.43 
Volume 183,615